Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134


MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors.

Lee YY, Yang YP, Huang MC, Wang ML, Yen SH, Huang PI, Chen YW, Chiou SH, Lan YT, Ma HI, Shih YH, Chen MT.

Cell Transplant. 2014;23(4-5):669-90. doi: 10.3727/096368914X678364.


Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor.

Chiou SH, Kao CL, Chen YW, Chien CS, Hung SC, Lo JF, Chen YJ, Ku HH, Hsu MT, Wong TT.

PLoS One. 2008 May 7;3(5):e2090. doi: 10.1371/journal.pone.0002090.


Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor.

Kao CL, Huang PI, Tsai PH, Tsai ML, Lo JF, Lee YY, Chen YJ, Chen YW, Chiou SH.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):219-28. doi: 10.1016/j.ijrobp.2008.12.035.


Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells.

Chang CJ, Chiang CH, Song WS, Tsai SK, Woung LC, Chang CH, Jeng SY, Tsai CY, Hsu CC, Lee HF, Huang CS, Yung MC, Liu JH, Lu KH.

Childs Nerv Syst. 2012 Mar;28(3):363-73. doi: 10.1007/s00381-011-1672-x. Epub 2012 Jan 17.


CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).

Choijamts B, Jimi S, Kondo T, Naganuma Y, Matsumoto T, Kuroki M, Iwasaki H, Emoto M.

Stem Cells. 2011 Oct;29(10):1485-95. doi: 10.1002/stem.711.


CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.

Chen YS, Wu MJ, Huang CY, Lin SC, Chuang TH, Yu CC, Lo JF.

PLoS One. 2011;6(11):e28053. doi: 10.1371/journal.pone.0028053. Epub 2011 Nov 28.


miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

Ma S, Tang KH, Chan YP, Lee TK, Kwan PS, Castilho A, Ng I, Man K, Wong N, To KF, Zheng BJ, Lai PB, Lo CM, Chan KW, Guan XY.

Cell Stem Cell. 2010 Dec 3;7(6):694-707. doi: 10.1016/j.stem.2010.11.010.


A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.

Choi SA, Wang KC, Phi JH, Lee JY, Park CK, Park SH, Kim SK.

Cancer Lett. 2012 Nov 28;324(2):221-30. doi: 10.1016/j.canlet.2012.05.026. Epub 2012 May 28.


Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133.

Chai S, Tong M, Ng KY, Kwan PS, Chan YP, Fung TM, Lee TK, Wong N, Xie D, Yuan YF, Guan XY, Ma S.

Oncotarget. 2014 Jul 30;5(14):5725-35.


Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.

Ma HI, Chiou SH, Hueng DY, Tai LK, Huang PI, Kao CL, Chen YW, Sytwu HK.

J Neurosurg. 2011 Mar;114(3):651-62. doi: 10.3171/2009.11.JNS091396. Epub 2010 Nov 5.


Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells.

Yang MY, Lee HT, Chen CM, Shen CC, Ma HI.

Int J Mol Sci. 2014 Jun 18;15(6):11013-29. doi: 10.3390/ijms150611013.


Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.

Wang W, Long L, Wang L, Tan C, Fei X, Chen L, Huang Q, Liang Z.

Cancer Lett. 2016 Feb 28;371(2):274-84. doi: 10.1016/j.canlet.2015.12.012. Epub 2015 Dec 17.


Identification of suitable endogenous control genes for microRNA expression profiling of childhood medulloblastoma and human neural stem cells.

Genovesi LA, Anderson D, Carter KW, Giles KM, Dallas PB.

BMC Res Notes. 2012 Sep 14;5:507. doi: 10.1186/1756-0500-5-507.


CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.

Shi CJ, Gao J, Wang M, Wang X, Tian R, Zhu F, Shen M, Qin RY.

World J Gastroenterol. 2011 Jun 28;17(24):2965-71. doi: 10.3748/wjg.v17.i24.2965.


microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.

Zhang J, Luo N, Luo Y, Peng Z, Zhang T, Li S.

Int J Oncol. 2012 Mar;40(3):747-56. doi: 10.3892/ijo.2011.1242. Epub 2011 Oct 24.


Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.

Annabi B, Rojas-Sutterlin S, Laflamme C, Lachambre MP, Rolland Y, Sartelet H, Béliveau R.

Mol Cancer Res. 2008 Jun;6(6):907-16. doi: 10.1158/1541-7786.MCR-07-2184.


PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.

Cheng RB, Ma RJ, Wang ZK, Yang SJ, Lin XZ, Rong H, Ma Y.

Mol Cell Biochem. 2011 Mar;349(1-2):149-57. doi: 10.1007/s11010-010-0669-1. Epub 2010 Nov 26.


Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.

Friedman GK, Moore BP, Nan L, Kelly VM, Etminan T, Langford CP, Xu H, Han X, Markert JM, Beierle EA, Gillespie GY.

Neuro Oncol. 2016 Feb;18(2):227-35. doi: 10.1093/neuonc/nov123. Epub 2015 Jul 16.


Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.

Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, Eramo A, Napoletano C, Gallo D, Perillo A, Nuti M, Pierelli L, Testa U, Scambia G, Ferrandina G.

Clin Cancer Res. 2009 Jul 1;15(13):4299-311. doi: 10.1158/1078-0432.CCR-08-1883. Epub 2009 Jun 9.


Isolation of cancer stem cells from transformed human mesenchymal stem cell line F6.

Xu X, Qian H, Zhu W, Zhang X, Yan Y, Wang M, Xu W.

J Mol Med (Berl). 2010 Nov;88(11):1181-90. doi: 10.1007/s00109-010-0659-5. Epub 2010 Aug 10.


Supplemental Content

Support Center